Clinical Trial Update: A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating intranasal budesonide aqueous spray for rhinitis during periods of high airborne pollution.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis

Drugs mentioned

• Budesonide aqueous spray (intranasal) (budesonide)

Snippet

Sponsor: Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | Conditions: Rhinitis | Phase 4 | Status: COMPLETED